Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients

NCT02602262 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2025-08-14

No results posted yet for this study

Summary

HIV-infected (HIV+) individuals who agree to accept and receive a solid organ transplant from an HIV+ deceased donor will be followed to determine the safety and efficacy of this practice. Some HIV+ individuals who receive a solid organ transplant from HIV-uninfected (HIV-) donors will also be followed.

Conditions

  • HIV Infection

Interventions

OTHER

HIV-infected deceased donor organ

HIV-infected deceased donor organ transplant

Sponsors & Collaborators

  • University of Colorado, Denver

    collaborator OTHER
  • Yale University

    collaborator OTHER
  • Georgetown University

    collaborator OTHER
  • Emory University

    collaborator OTHER
  • Rush University Medical Center

    collaborator OTHER
  • University of Illinois at Chicago

    collaborator OTHER
  • Indiana University

    collaborator OTHER
  • University of Maryland

    collaborator OTHER
  • Columbia University

    collaborator OTHER
  • Icahn School of Medicine at Mount Sinai

    collaborator OTHER
  • Weill Medical College of Cornell University

    collaborator OTHER
  • University of Pittsburgh Medical Center

    collaborator OTHER
  • Methodist Health System

    collaborator OTHER
  • Northwestern University

    collaborator OTHER
  • NYU Langone Health

    collaborator OTHER
  • University of Virginia

    collaborator OTHER
  • Washington University School of Medicine

    collaborator OTHER
  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH
  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Christine Durand, MD · Johns Hopkins University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2020-06-12
Completion
2023-06-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02602262 on ClinicalTrials.gov